No abstract available
Publication types
-
Consensus Development Conference
MeSH terms
-
Abatacept
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / therapeutic use*
-
Female
-
Humans
-
Immunoconjugates / adverse effects
-
Immunoconjugates / therapeutic use
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use*
-
Male
-
Polyethylene Glycols / adverse effects
-
Polyethylene Glycols / therapeutic use
-
Pregnancy
-
Rheumatic Diseases / complications
-
Rheumatic Diseases / drug therapy*
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
Urate Oxidase / adverse effects
-
Urate Oxidase / therapeutic use
Substances
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Immunoconjugates
-
Immunosuppressive Agents
-
Tumor Necrosis Factor-alpha
-
Polyethylene Glycols
-
belimumab
-
Abatacept
-
Urate Oxidase
-
tocilizumab
-
Pegloticase